Recent Study: EpiCept Corporation - Product Pipeline Review - 2013

From: Fast Market Research, Inc.
Published: Thu Jun 13 2013

Global Market Direct's pharmaceuticals report, "EpiCept Corporation - Product Pipeline Review - 2013" provides data on the EpiCept Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, EpiCept Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from EpiCept Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at


* EpiCept Corporation - Brief EpiCept Corporation overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of EpiCept Corporation human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of EpiCept Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the EpiCept Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Evaluate EpiCept Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of EpiCept Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the EpiCept Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with EpiCept Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of EpiCept Corporation and identify potential opportunities in those areas.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- EpiCept Corporation - Product Pipeline Review - 2012
- Elan Corporation, plc - Product Pipeline Review - 2013
- Yuhan Corporation - Product Pipeline Review - 2013
- Aphios Corporation - Product Pipeline Review - 2013
- Generex Biotechnology Corporation - Product Pipeline Review - 2013
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »